1. Home
  2. CHCO vs ANIP Comparison

CHCO vs ANIP Comparison

Compare CHCO & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHCO
  • ANIP
  • Stock Information
  • Founded
  • CHCO 1957
  • ANIP 2001
  • Country
  • CHCO United States
  • ANIP United States
  • Employees
  • CHCO N/A
  • ANIP N/A
  • Industry
  • CHCO Major Banks
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHCO Finance
  • ANIP Health Care
  • Exchange
  • CHCO Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • CHCO 1.8B
  • ANIP 1.4B
  • IPO Year
  • CHCO N/A
  • ANIP N/A
  • Fundamental
  • Price
  • CHCO $129.69
  • ANIP $66.50
  • Analyst Decision
  • CHCO Hold
  • ANIP Strong Buy
  • Analyst Count
  • CHCO 2
  • ANIP 9
  • Target Price
  • CHCO $127.50
  • ANIP $80.56
  • AVG Volume (30 Days)
  • CHCO 173.5K
  • ANIP 280.2K
  • Earning Date
  • CHCO 07-22-2025
  • ANIP 08-05-2025
  • Dividend Yield
  • CHCO 2.44%
  • ANIP N/A
  • EPS Growth
  • CHCO 6.95
  • ANIP N/A
  • EPS
  • CHCO 8.30
  • ANIP N/A
  • Revenue
  • CHCO $300,872,000.00
  • ANIP $674,068,000.00
  • Revenue This Year
  • CHCO $6.77
  • ANIP $30.84
  • Revenue Next Year
  • CHCO $1.73
  • ANIP $7.39
  • P/E Ratio
  • CHCO $15.62
  • ANIP N/A
  • Revenue Growth
  • CHCO 4.61
  • ANIP 30.27
  • 52 Week Low
  • CHCO $102.22
  • ANIP $52.50
  • 52 Week High
  • CHCO $137.28
  • ANIP $77.00
  • Technical
  • Relative Strength Index (RSI)
  • CHCO 55.09
  • ANIP 51.15
  • Support Level
  • CHCO $120.50
  • ANIP $64.27
  • Resistance Level
  • CHCO $126.36
  • ANIP $68.60
  • Average True Range (ATR)
  • CHCO 2.77
  • ANIP 1.95
  • MACD
  • CHCO -0.32
  • ANIP -0.05
  • Stochastic Oscillator
  • CHCO 46.55
  • ANIP 39.41

About CHCO City Holding Company

City Holding Co is a financial holding company. The company conducts its principal activities through its wholly-owned subsidiary, City National Bank of West Virginia (City National). Through the bank, it provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, savings accounts, credit cards and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance products, and others. The company's business activities are currently limited to one reportable business segment, which is community banking.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: